-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2002_SummaryStats_10PCT_SAMPLE_B.PDF
January 01, 2002 - 0.00 29.00 1.42 1.77
PAY1 : Primary expected payer (uniform) 784349 1049 1.00 6.00 2.23 1.18
PAY2 : Secondary … 32 Monday, June 6, 2005
DRG18 Frequency
Percent
of
Total
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS 48 0.01
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 542 0.07
467: OTHER … JOINT & LIMB REATTACHMENT PROCEDURES OF UPPER EXTREMITY 545 0.07
492: CHEMOTHERAPY W ACUTE LEUKEMIA AS SECONDARY … Leukemias 891 0.11
40: Multiple myeloma 342 0.04
41: Cancer, other Unspecified primary 220 0.03
42: Secondary
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2000_SummaryStats_10PCT_SAMPLE_B.PDF
January 01, 2000 - 0.00 25.00 1.38 1.72
PAY1 : Primary expected payer (uniform) 742077 3022 1.00 6.00 2.26 1.18
PAY2 : Secondary … NEOPL W OTHER O.R.PROC 127 0.02
409: RADIOTHERAPY 186 0.02
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS 61 0.01
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 707 0.09
467: OTHER … JOINT & LIMB REATTACHMENT PROCEDURES OF UPPER EXTREMITY 423 0.06
492: CHEMOTHERAPY W ACUTE LEUKEMIA AS SECONDARY … Leukemias 758 0.10
40: Multiple myeloma 347 0.05
41: Cancer, other Unspecified primary 175 0.02
42: Secondary
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2001_SummaryStats.PDF
January 01, 2001 - 30.00 1.41 1.77
PAY1 : Primary expected payer (uniform) 7432848 19879 1.00 6.00 2.23 1.17
PAY2 : Secondary … Distribution for DRG18
DRG18 Frequency
Percent
of
Total
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS 640 0.01
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 5129 0.07
467: … & LIMB REATTACHMENT PROCEDURES OF UPPER EXTREMITY 4612 0.06
492: CHEMOTHERAPY W ACUTE LEUKEMIA AS SECONDARY … Percent
of
Total
98: Essential hypertension 12761 0.17
99: Hypertension with complications and secondary
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2001_SummaryStats_10PCT_SAMPLE_A.PDF
January 01, 2001 - 0.00 25.00 1.41 1.77
PAY1 : Primary expected payer (uniform) 743284 1989 1.00 6.00 2.23 1.17
PAY2 : Secondary … NEOPL W OTHER O.R.PROC 108 0.01
409: RADIOTHERAPY 139 0.02
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS 60 0.01
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 545 0.07
467: OTHER … JOINT & LIMB REATTACHMENT PROCEDURES OF UPPER EXTREMITY 473 0.06
492: CHEMOTHERAPY W ACUTE LEUKEMIA AS SECONDARY … Leukemias 798 0.11
40: Multiple myeloma 353 0.05
41: Cancer, other Unspecified primary 166 0.02
42: Secondary
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2004_SummaryStats_CORE.PDF
January 01, 2004 - 30.00 1.48 1.84
PAY1 : Primary expected payer (uniform) 7990344 14227 1.00 6.00 2.23 1.18
PAY2 : Secondary … W CC 12477 0.16
464: SIGNS & SYMPTOMS W/O CC 4054 0.05
465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 597 0.01
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 5507 0.07
467: … & LIMB REATTACHMENT PROCEDURES OF UPPER EXTREMITY 7084 0.09
492: CHEMOTHERAPY W ACUTE LEUKEMIA AS SECONDARY … Percent
of
Total
98: Essential hypertension 15321 0.19
99: Hypertension with complications and secondary
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2000_SummaryStats.PDF
January 01, 2000 - 28.00 1.38 1.72
PAY1 : Primary expected payer (uniform) 7421373 29619 1.00 6.00 2.25 1.18
PAY2 : Secondary … Distribution for DRG18
DRG18 Frequency
Percent
of
Total
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS 664 0.01
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 6733 0.09
467: … & LIMB REATTACHMENT PROCEDURES OF UPPER EXTREMITY 4018 0.05
492: CHEMOTHERAPY W ACUTE LEUKEMIA AS SECONDARY … Percent
of
Total
98: Essential hypertension 12347 0.17
99: Hypertension with complications and secondary
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2000_SummaryStats_10PCT_SAMPLE_A.PDF
January 01, 2000 - 0.00 25.00 1.39 1.72
PAY1 : Primary expected payer (uniform) 742165 2934 1.00 6.00 2.26 1.18
PAY2 : Secondary … NEOPL W OTHER O.R.PROC 104 0.01
409: RADIOTHERAPY 177 0.02
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS 54 0.01
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 646 0.09
467: OTHER … JOINT & LIMB REATTACHMENT PROCEDURES OF UPPER EXTREMITY 375 0.05
492: CHEMOTHERAPY W ACUTE LEUKEMIA AS SECONDARY … Leukemias 764 0.10
40: Multiple myeloma 354 0.05
41: Cancer, other Unspecified primary 162 0.02
42: Secondary
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol4/Miranda.pdf
July 01, 2004 - This body of research studies suggested not only which messages to emphasize,
but also which secondary … • Who is the target audience, and what secondary audiences do we need
to consider?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2025-update-disposition-comments.pdf
January 01, 2025 - Peer Reviewer
#2
Methods Please clarify the procedures followed for identifying
secondary publications … this with
the study’s primary
author we have
removed Yuen 2015
as a study, and
recoded it as a
secondary
-
hcup-us.ahrq.gov/reports/statbriefs/sb282-COVID-19-AllHospital.pdf
December 01, 2020 - Secondary diagnoses are conditions that coexist at the time of admission that
require or affect patient … All-listed diagnoses include the principal diagnosis plus the secondary conditions.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-loss-surgery_research-protocol.pdf
December 14, 2010 - • Secondary outcomes:
o healthcare utilization/economics
o quality of life measures
• Adverse … • Secondary outcomes: Same as in KQ1.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-informed-care-disposition-comments.pdf
January 14, 2025 - includes primary prevention;
identification and response in primary care and other health settings
(secondary … anti-racism and cultural humility as part of TIC;
5) the intersection of trauma and child development;
6) secondary
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay_research-protocol.pdf
May 02, 2011 - polyclonal hypergammaglobulinemia or in renal insufficiency
where free monoclonal light chains are retained secondary … such that a given study that reports its
primary outcome well but did an incomplete analysis of a secondary
-
hcup-us.ahrq.gov/reports/statbriefs/sb118.jsp
August 01, 2011 - the most common all-listed procedures received by children in U.S. hospitals, including principal and secondary … Secondary diagnoses are concomitant conditions that coexist at the time of admission or that develop
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_10-user-guide-to-ocer_130129.pdf
January 01, 2011 - o
Propose the model that will be used
for primary and secondary analysis
objectives. … adjusting
for confounding (e.g., multiple regression model,
propensity scores, instrumental variable [as secondary
-
digital.ahrq.gov/sites/default/files/docs/publication/r03hs018250-vawdrey-final-report-2011.pdf
January 01, 2011 - also observed that many lists contained
additional information included as annotations, prompting a secondary … This observation prompted a secondary qualitative analysis of the medication lists based on a
grounded
-
cds.ahrq.gov/taxonomy/term/57941
August 23, 2024 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
www.ahrq.gov/sites/default/files/2024-09/park-report.pdf
January 01, 2024 - We performed a secondary data
analysis of observational, cross-sectional data from national samples … We performed a secondary data analysis of
observational, cross-sectional data from national samples … For this
secondary data analysis study, the AHA Annual Survey of Hospitals, the CMS Hospital
Compare
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/abate/introduction/scientific-rationale.pdf
March 01, 2022 - upon pragmatic needs or
literature evidence other than from the ABATE Infection trial.74 For example, secondary … Efficacy and safety of 2% mupirocin ointment in the
treatment of primary and secondary skin infections … Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of
primary and secondary skin
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/TzddJozNQQZYmTohr64wMz
June 07, 2016 - Symptoms correspond to stages of infection in-
cluding primary, secondary, early- and late-latent, and … southern and western United
States.2,8,9 Men who have sex with men accounted for 61% of all pri-
mary and secondary … Test
Sensitivity by Stage of Untreated Syphilis, % (Range)b
Specificity, %
(Range)bMixed Primary Secondary